Analysis of Tumor Suppressor Genes Based on Gene Ontology and the KEGG Pathway

Cancer is a serious disease that causes many deaths every year. We urgently need to design effective treatments to cure this disease. Tumor suppressor genes (TSGs) are a type of gene that can protect cells from becoming cancerous. In view of this, correct identification of TSGs is an alternative method for identifying effective cancer therapies. In this study, we performed gene ontology (GO) and pathway enrichment analysis of the TSGs and non-TSGs. Some popular feature selection methods, including minimum redundancy maximum relevance (mRMR) and incremental feature selection (IFS), were employed to analyze the enrichment features. Accordingly, some GO terms and KEGG pathways, such as biological adhesion, cell cycle control, genomic stability maintenance and cell death regulation, were extracted, which are important factors for identifying TSGs. We hope these findings can help in building effective prediction methods for identifying TSGs and thereby, promoting the discovery of effective cancer treatments.

[1]  Majid Mohammad Beigi,et al.  Prediction of allergenic proteins by means of the concept of Chou's pseudo amino acid composition and a machine learning approach. , 2012 .

[2]  S. Sathiya Keerthi,et al.  Improvements to Platt's SMO Algorithm for SVM Classifier Design , 2001, Neural Computation.

[3]  Chris H. Q. Ding,et al.  Minimum redundancy feature selection from microarray gene expression data , 2003, Computational Systems Bioinformatics. CSB2003. Proceedings of the 2003 IEEE Bioinformatics Conference. CSB2003.

[4]  W. Tilley,et al.  Breast and prostate cancer: more similar than different , 2010, Nature Reviews Cancer.

[5]  Dung-Fang Lee,et al.  Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer. , 2007, Cancer research.

[6]  H. Cramér.  Mathematical methods of statistics , 1947 .

[7]  Alexei Vazquez,et al.  The genetics of the p53 pathway, apoptosis and cancer therapy , 2008, Nature Reviews Drug Discovery.

[8]  I. Hickson,et al.  Caretaker tumour suppressor genes that defend genome integrity. , 2002, Trends in molecular medicine.

[9]  S. West,et al.  Regulatory Control of the Resolution of DNA Recombination Intermediates during Meiosis and Mitosis , 2011, Cell.

[10]  Tilman Brummer,et al.  Mutated in colorectal cancer protein modulates the NFκB pathway. , 2012, Anticancer research.

[11]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[12]  S. Jacob,et al.  Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy , 2005, Cancer Gene Therapy.

[13]  Min Sung Kim,et al.  Frameshift mutations of tumor suppressor gene EP300 in gastric and colorectal cancers with high microsatellite instability. , 2013, Human pathology.

[14]  Fuhui Long,et al.  Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy , 2003, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[15]  M. Kendall,et al.  The advanced theory of statistics , 1945 .

[16]  D. Spyropoulos,et al.  The study of HOX gene function in hematopoietic, breast and lung carcinogenesis. , 2003, Anticancer research.

[17]  K. Aldape,et al.  NFKBIA deletion in glioblastomas. , 2011, The New England journal of medicine.

[18]  Carlos Caldas,et al.  Mutations truncating the EP300 acetylase in human cancers , 2000, Nature Genetics.

[19]  A. Esmaeili,et al.  Prediction of GABAA receptor proteins using the concept of Chou's pseudo-amino acid composition and support vector machine. , 2011, Journal of theoretical biology.

[20]  Jean-Loup Faulon,et al.  Predicting protein-protein interactions using signature products , 2005, Bioinform..

[21]  D. Reisman,et al.  The SWI/SNF complex and cancer , 2009, Oncogene.

[22]  Stephen C. West,et al.  Holliday junction resolution: Regulation in space and time , 2014, DNA repair.

[23]  A. Shlien,et al.  Copy number variations and cancer susceptibility , 2010, Current opinion in oncology.

[24]  H. Cramér.  Mathematical Methods of Statistics (PMS-9), Volume 9 , 1946 .

[25]  K. Ishizaki,et al.  Mutation spectrum of the retinoblastoma gene in osteosarcomas. , 1994, Cancer research.

[26]  S. Hardy,et al.  Inside the human cancer tyrosine phosphatome , 2010, Nature Reviews Cancer.

[27]  Lei Chen,et al.  Prediction of Metabolic Pathway Using Graph Property, Chemical Functional Group and Chemical Structural Set , 2013 .

[28]  W. Park,et al.  Inactivating mutations of caspase-8 gene in colorectal carcinomas. , 2003, Gastroenterology.

[29]  Xin Lu,et al.  Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells. , 2006, Cell research.

[30]  M. Daly,et al.  Genetic Mapping in Human Disease , 2008, Science.

[31]  Gregory D. Schuler,et al.  Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.

[32]  James R. Goldenring,et al.  Gastric Cancer Originating from Bone Marrow-Derived Cells , 2004, Science.

[33]  M. Ding,et al.  The role of glycogen synthase kinase 3beta in the transformation of epidermal cells. , 2007, Cancer research.

[34]  S. Sukumar,et al.  Compromised HOXA5 function can limit p53 expression in human breast tumours , 2000, Nature.

[35]  J. Carazo,et al.  GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists , 2007, Genome Biology.

[36]  K. Luoto,et al.  A functionally distinct member of the DP family of E2F subunits , 2006, Oncogene.

[37]  Jing Lu,et al.  A hybrid method for prediction and repositioning of drug Anatomical Therapeutic Chemical classes. , 2014, Molecular bioSystems.

[38]  K. Vousden,et al.  p53 mutations in cancer , 2013, Nature Cell Biology.

[39]  Ron Kohavi,et al.  A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection , 1995, IJCAI.

[40]  R. Auchus,et al.  Steroid biosynthesis and prostate cancer , 2012, Steroids.

[41]  D. Livingston,et al.  In search of the tumour-suppressor functions of BRCA1 and BRCA2 , 2000, Nature.

[42]  อนิรุธ สืบสิงห์,et al.  Data Mining Practical Machine Learning Tools and Techniques , 2014 .

[43]  G. Broggi,et al.  Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells , 2006, Nature.

[44]  Susumu Goto,et al.  KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..

[45]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[46]  John C. Platt,et al.  Fast training of support vector machines using sequential minimal optimization, advances in kernel methods , 1999 .

[47]  W. Stetler-Stevenson,et al.  Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. , 2010, Seminars in cancer biology.

[48]  Ian H. Witten,et al.  Stacking Bagged and Dagged Models , 1997, ICML.

[49]  W. Lee,et al.  Human retinoblastoma susceptibility gene: cloning, identification, and sequence , 1987, Science.

[50]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[51]  Karen H. Vousden,et al.  p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.

[52]  Ryan S. Lee,et al.  Linking the SWI/SNF complex to prostate cancer , 2013, Nature Genetics.

[53]  Pierre Baldi,et al.  Assessing the accuracy of prediction algorithms for classification: an overview , 2000, Bioinform..

[54]  S A Forbes,et al.  The Catalogue of Somatic Mutations in Cancer (COSMIC) , 2008, Current protocols in human genetics.

[55]  C. Preudhomme,et al.  Cooperating gene mutations in acute myeloid leukemia: a review of the literature , 2008, Leukemia.

[56]  G. Berx,et al.  The cell-cell adhesion molecule E-cadherin , 2008, Cellular and Molecular Life Sciences.

[57]  Xin Lu,et al.  Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells , 2006, Cell Research.

[58]  D. Busam,et al.  SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. , 2013, Cancer research.

[59]  R. Derynck,et al.  Smads: transcriptional activators of TGF-beta responses. , 1998, Cell.

[60]  A. Giordano,et al.  RB and cell cycle progression , 2006, Oncogene.

[61]  J. Thrasher,et al.  GSK-3β promotes cell survival by modulating Bif-1-dependent autophagy and cell death , 2010, Journal of Cell Science.

[62]  Zhongming Zhao,et al.  TSGene: a web resource for tumor suppressor genes , 2012, Nucleic Acids Res..

[63]  Xuan Zhou,et al.  Classification of G-protein coupled receptors based on support vector machine with maximum relevance minimum redundancy and genetic algorithm , 2010, BMC Bioinformatics.

[64]  U. Schlegel,et al.  Mutational analysis of the human p53 gene in malignant melanoma. , 1991, Pigment cell research.

[65]  Zhiyong Lu,et al.  Generif Quality Assurance as Summary Revision , 2006, Pacific Symposium on Biocomputing.

[66]  M. Knowles.  Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? , 2006, Carcinogenesis.

[67]  Lei Chen,et al.  Prediction of interactiveness between small molecules and enzymes by combining gene ontology and compound similarity , 2009, J. Comput. Chem..

[68]  J. Herman,et al.  GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer , 2009, Clinical Cancer Research.

[69]  G. Banna,et al.  BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling. , 2001, Cancer treatment reviews.

[70]  Gustavo Pedraza-Alva,et al.  Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation , 2008, Science.

[71]  R. Derynck,et al.  Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.

[72]  J. Sage,et al.  Cellular mechanisms of tumour suppression by the retinoblastoma gene , 2008, Nature Reviews Cancer.

[73]  F. Brasseur,et al.  A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma , 1997, The Journal of experimental medicine.

[74]  Lexun Xue,et al.  An activated Notch1 signaling pathway inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma cell line EC9706. , 2008, International journal of oncology.

[75]  Y. Takano,et al.  Phosphorylated GSK3beta-ser9 and EGFR are good prognostic factors for lung carcinomas. , 2007, Anticancer research.

[76]  Chris H. Q. Ding,et al.  Multi-class protein fold recognition using support vector machines and neural networks , 2001, Bioinform..

[77]  ZhiSong He,et al.  Computational Analysis of Protein Tyrosine Nitration , 2010 .

[78]  Kuo-Chen Chou,et al.  Predicting the network of substrate-enzyme-product triads by combining compound similarity and functional domain composition , 2010, BMC Bioinformatics.

[79]  Masashi Narita,et al.  Reversal of human cellular senescence: roles of the p53 and p16 pathways , 2003, The EMBO journal.

[80]  Y. Shiloh,et al.  The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. , 2013, Nature reviews. Molecular cell biology.

[81]  C. Ding,et al.  Gene selection algorithm by combining reliefF and mRMR , 2007, 2007 IEEE 7th International Symposium on BioInformatics and BioEngineering.

[82]  J. Hays,et al.  DNA mismatch repair proteins: potential guardians against genomic instability and tumorigenesis induced by ultraviolet photoproducts. , 2003, The Journal of investigative dermatology.

[83]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[84]  R. Coleman,et al.  The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer , 2012, Clinical Cancer Research.

[85]  Value of bilateral breast cancer for identification of rare recessive at-risk alleles: evidence for the role of homozygous GEN1 c.2515_2519delAAGTT mutation , 2013, Familial Cancer.

[86]  S. West,et al.  Aberrant chromosome morphology in human cells defective for Holliday junction resolution , 2011, Nature.

[87]  G. Tamura.  Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. , 2006, World journal of gastroenterology.

[88]  M. Moses,et al.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[89]  Ruiguang Song,et al.  Risk Factor Redistribution of the National HIV/AIDS Surveillance Data: An Alternative Approach , 2008, Public health reports.

[90]  F. Setién,et al.  Regulation of SNAIL1 and E-cadherin function by DNMT1 in a DNA methylation-independent context , 2011, Nucleic acids research.

[91]  Hassan Mohabatkar,et al.  Prediction of allergenic proteins by means of the concept of Chou's pseudo amino acid composition and a machine learning approach. , 2012, Medicinal chemistry (Shariqah (United Arab Emirates)).

[92]  Sunil Singhal,et al.  Prognostic Implications of Cell Cycle, Apoptosis, and Angiogenesis Biomarkers in Non–Small Cell Lung Cancer: A Review , 2005, Clinical Cancer Research.

[93]  Paul Tempst,et al.  Regulation of p53 activity through lysine methylation , 2004, Nature.

[94]  A. Merchant,et al.  Targeting Hedgehog — a Cancer Stem Cell Pathway , 2010, Clinical Cancer Research.

[95]  A. Strasser,et al.  The role of the apoptotic machinery in tumor suppression. , 2012, Cold Spring Harbor perspectives in biology.

[96]  M. Jackson,et al.  Rb/E2F4 and Smad2/3 link survivin to TGF-β-induced apoptosis and tumor progression , 2008, Oncogene.

[97]  M. Katoh.  Networking of WNT, FGF, Notch, BMP, and Hedgehog Signaling Pathways during Carcinogenesis , 2007, Stem Cell Reviews.

[98]  A. Böhle,et al.  Bladder cancer. I. Molecular and genetic basis of carcinogenesis. , 2001, European urology.

[99]  K. Chou,et al.  Predicting Anatomical Therapeutic Chemical (ATC) Classification of Drugs by Integrating Chemical-Chemical Interactions and Similarities , 2012, PloS one.

[100]  A. Tomkinson,et al.  DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis , 1999, Oncogene.

[101]  Robert Brown,et al.  HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia. , 2007, Carcinogenesis.

[102]  Kuo-Chen Chou,et al.  Deciphering the effects of gene deletion on yeast longevity using network and machine learning approaches. , 2012, Biochimie.

[103]  R. Cardiff,et al.  Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. , 2005, Cancer research.

[104]  T. Jacks,et al.  Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. , 2000, Genes & development.

[105]  V. Kosma,et al.  Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. , 1995, European journal of cancer.

[106]  Xuejun Zhang,et al.  Identification of the cylindromatosis tumor-suppressor gene responsible for multiple familial trichoepithelioma. , 2004, The Journal of investigative dermatology.

[107]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[108]  Michael J. Terry,et al.  HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas , 2002, Oncogene.

[109]  L. Staudt,et al.  Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. , 2007, Cancer cell.

[110]  Yu-Dong Cai,et al.  Prediction of Protein-Protein Interaction Sites by Random Forest Algorithm with mRMR and IFS , 2012, PloS one.

[111]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[112]  A. V. van Rossum,et al.  Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. , 2000, Genes & development.

[113]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[114]  M. Hishida,et al.  Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis. , 2013, International journal of oncology.

[115]  C. Sherr,et al.  Principles of Tumor Suppression , 2004, Cell.

[116]  B. Matthews.  Comparison of the predicted and observed secondary structure of T4 phage lysozyme. , 1975, Biochimica et biophysica acta.

[117]  Diana M. Mitrea,et al.  Disorder-function relationships for the cell cycle regulatory proteins p21 and p27 , 2012, Biological chemistry.

[118]  P. Hanawalt,et al.  p53-Mediated DNA Repair Responses to UV Radiation: Studies of Mouse Cells Lacking p53, p21, and/orgadd45 Genes , 2000, Molecular and Cellular Biology.

[119]  S. Echigo,et al.  Zebularine suppresses the apoptotic potential of 5-fluorouracil via cAMP/PKA/CREB pathway against human oral squamous cell carcinoma cells , 2009, Cancer Chemotherapy and Pharmacology.